Trending News
News
News
Promising New Compound Kills Several Hard-To-Treat Cancers
According to a study, a newly synthesized compound kills a range of hard-to-treat cancer types by targeting a previously unexploited vulnerability.
News
Diversity in Genetic Research Is Key to Enhancing Treatment of Chronic Diseases in Africa
Researchers have used genetic data from 1.4 million people of diverse ancestry across sub-Saharan Africa to investigate how the use of diverse and representative data can impact our ability to predict risk of disease.
News
Chemo and Immunotherapy Combination Yields Promising Results Against Pancreatic Cancer
A randomized clinical trial found that a combination of immunotherapy and chemotherapy treatment boosted the one-year survival rate of pancreatic cancer by over 60%.
News
Immunotherapy Combination Could Extend Lives of Lung Cancer Patients
Late-breaking research from Cedars-Sinai Cancer finds an immunotherapy drug combination in Phase II clinical trials improves survival for patients with immunotherapy-resistant, non-small cell lung cancer.
News
Receptor Helps Cocaine Latch on to Brain Cells
Scientists have identified a receptor, known as BASP1, that is capable of binding cocaine at very low doses.
News
Repurposed Cancer Drugs Treat Neuroinflammatory Diseases
A repurposed FDA-approved drug combined with a novel drug carrier could be used to target microglia and treat neuroinflammatory diseases.
News
CAR T-Cell Therapy Targets Cells That Cause Leukemia Relapse
In a study, genetically engineered immune cells successfully targeted the specific cancer cells that may be responsible for the relapse of acute myeloid leukemia.
News
Drug-Carrying Nanoparticles Designed To Cross Blood‒Brain Barrier More Easily
Replicating the human blood–brain barrier has enabled the development of drug-carrying nanoparticles that can enter the brain more easily, potentially making brain cancers easier to treat.
News
"Masked" Cancer Drug Activates Once It Reaches the Tumor To Reduce Side Effects
Researchers have long suspected that interleukin-12 could be a powerful cancer treatment, but it can cause unwanted adverse effects. Now, researchers have developed a version of the molecule that remains inactive until it reaches the tumor site.
News
New Clinical Trial of Monoclonal Antibody for Asthma
The NIH has launched a clinical trial testing whether a monoclonal antibody, dupilumab, can reduce asthma attacks and improve lung function and asthma symptoms in children with poorly controlled allergic asthma who live in low-income urban neighborhoods.
Advertisement